• Corpus ID: 212560485

Advancement of polymer–based nanoparticles as smart drug delivery systems in neurodegenerative medicine

  title={Advancement of polymer–based nanoparticles as smart drug delivery systems in neurodegenerative medicine},
  author={Keyanpour Rad Mansoor and Kianpour Rad Sima and Kianpour Rad Soheila},
Neurodegenerative diseases (NDs), such as Alzheimer, Parkinson, amyotrophic lateral sclerosis (ALS), strokes, spinal cord injuries, glioblastoma, Huntington’s and others are caused by progressive dysfunction and death of neurons and are becoming increasingly prevalent and rising rapidly with advancement of age.1,2 Such brain disorders are usually caused by highly complex formation process of variety of cytotoxic protein aggregates with different structures and morphologies. The protein… 
1 Citations

Tables from this paper

Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain

A broad overview of present-day strategies for brain drug delivery is provided, emphasizing novel delivery systems and novel non-nanoparticle strategies such as using viral and peptide vectors and other non-invasive techniques to enhance brain uptake of drugs.



Advances in the treatment of neurodegenerative disorders employing nanoparticles.

The aim of this review is to summarize the last patents, clinical trials and news related with nanoparticles technology for the treatment of neurodegenerative diseases.

Neurological disorders and therapeutics targeted to surmount the blood–brain barrier

This review addresses the pathophysiology of the more common neurological disorders and novel drug candidates, along with targeted nanoparticle applications for brain delivery, and yields some promising results.

Old Drugs as New Treatments for Neurodegenerative Diseases

There is an urgent need for new treatments for this kind of disease, since the World Health Organization has predicted that neurodegenerative diseases affecting motor function will become the second-most prevalent cause of death in the next 20 years.

The blood–brain barrier in neurodegenerative disease: a rhetorical perspective

This review discusses recent reports suggesting the involvement of peripheral factors including toxins and elements of adaptive immunity that may not only play a role in pathogenesis, but also progression of neurodegenerative diseases.